JAK2 mutations, resulting in constitutive activation of the JAK-STAT signaling pathway, are present in ~4% of BCP ALL in general but are particularly common (~20%) in BCP ALL in children with Down syndrome (DS) [9]. The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.